These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 32556933)
1. Should Total Thyroidectomy Be Recommended for Patients with Familial Non-medullary Thyroid Cancer? Kim YS; Seo M; Park SH; Ju SY; Kim ES World J Surg; 2020 Sep; 44(9):3022-3027. PubMed ID: 32556933 [TBL] [Abstract][Full Text] [Related]
2. Is Familial Nonmedullary Thyroid Cancer A More Aggressive Type of Thyroid Cancer? Muallem Kalmovich L; Jabarin B; Koren S; Or K; Marcus E; Tkacheva I; Benbassat C; Steinschneider M Laryngoscope; 2021 Feb; 131(2):E677-E681. PubMed ID: 32761812 [TBL] [Abstract][Full Text] [Related]
3. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446 [TBL] [Abstract][Full Text] [Related]
4. Comparison Between Clinicopathological Characteristics, Yang T; Huang L; Chen C; Luo H; Jiang Y Front Oncol; 2021; 11():616974. PubMed ID: 34926235 [TBL] [Abstract][Full Text] [Related]
5. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Capezzone M; Marchisotta S; Cantara S; Busonero G; Brilli L; Pazaitou-Panayiotou K; Carli AF; Caruso G; Toti P; Capitani S; Pammolli A; Pacini F Endocr Relat Cancer; 2008 Dec; 15(4):1075-81. PubMed ID: 18832444 [TBL] [Abstract][Full Text] [Related]
6. [Clinical and biological features of familial nonmedullary thyroid carcinoma]. Gao J; Yu Y; Li X; Zhao J; Zhao C; Zhao J; Liu Y; Li Y; Gao M Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):202-6. PubMed ID: 24785281 [TBL] [Abstract][Full Text] [Related]
7. Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study. ESES Vienna presentation. Hillenbrand A; Varhaug JE; Brauckhoff M; Pandev R; Haufe S; Dotzenrath C; Köberle R; Hoffmann R; Klein G; Kadmon M; Negele T; Hagieva T; Henne-Bruns D; Luster M; Weber T Langenbecks Arch Surg; 2010 Sep; 395(7):851-8. PubMed ID: 20683623 [TBL] [Abstract][Full Text] [Related]
8. Significance of multifocality in papillary thyroid carcinoma. Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic features of familial nonmedullary thyroid carcinoma. Fan YF; Zhang B; Yang X; Shang ZH; Liu HF; Xie Y; Liu YW; Gao WS; Wu Q; Li XY Chin Med J (Engl); 2015 Apr; 128(8):1037-41. PubMed ID: 25881596 [TBL] [Abstract][Full Text] [Related]
10. Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer. Moses W; Weng J; Kebebew E Thyroid; 2011 Apr; 21(4):367-71. PubMed ID: 21190444 [TBL] [Abstract][Full Text] [Related]
11. Familial Non-Medullary Thyroid Carcinoma in Pediatric Age: Our Surgical Experience. Spinelli C; Piccolotti I; Bertocchini A; Morganti R; Materazzi G; Tonacchera M; Strambi S World J Surg; 2021 Aug; 45(8):2473-2479. PubMed ID: 33891138 [TBL] [Abstract][Full Text] [Related]
12. Familial non-medullary thyroid cancer: a matched-case control study. Maxwell EL; Hall FT; Freeman JL Laryngoscope; 2004 Dec; 114(12):2182-6. PubMed ID: 15564841 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer. Zhao H; Huang T; Li H Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667 [TBL] [Abstract][Full Text] [Related]
14. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines. Mitchell AL; Gandhi A; Scott-Coombes D; Perros P J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128 [TBL] [Abstract][Full Text] [Related]
15. Comparison Between Familial and Sporadic Non-medullary Thyroid Carcinoma: A Retrospective Individual Risk Factor-Matched Cohort Study. Lee YM; Jeon MJ; Kim WW; Chung KW; Baek JH; Shong YK; Sung TY; Hong SJ Ann Surg Oncol; 2021 Mar; 28(3):1722-1730. PubMed ID: 32803550 [TBL] [Abstract][Full Text] [Related]
16. Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma. Lee YM; Yoon JH; Yi O; Sung TY; Chung KW; Kim WB; Hong SJ J Surg Oncol; 2014 Feb; 109(2):168-73. PubMed ID: 24132694 [TBL] [Abstract][Full Text] [Related]
17. Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Alsanea O; Wada N; Ain K; Wong M; Taylor K; Ituarte PH; Treseler PA; Weier HU; Freimer N; Siperstein AE; Duh QY; Takami H; Clark OH Surgery; 2000 Dec; 128(6):1043-50;discussion 1050-1. PubMed ID: 11114641 [TBL] [Abstract][Full Text] [Related]
18. Clinical Analysis of Familial Nonmedullary Thyroid Carcinoma. Zhang Q; Yang S; Meng XY; Chen G; Pang RZ World J Surg; 2016 Mar; 40(3):570-3. PubMed ID: 26711636 [TBL] [Abstract][Full Text] [Related]
19. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy. Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465 [TBL] [Abstract][Full Text] [Related]
20. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice. Rubinstein JC; Herrick-Reynolds K; Dinauer C; Morotti R; Solomon D; Callender GG; Christison-Lagay ER J Surg Res; 2020 May; 249():58-66. PubMed ID: 31923715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]